skip navigation

Skip Nav

Education Materials

AIDSinfo Glossary Search

A - Z Index

glossary a-z index

Pediatric AIDS Clinical Trials Group 076 (PACTG 076) Audio (En español)

A federally funded study that determined that the risk of mother-to-child transmission (MTCT) of HIV could be reduced by nearly 70% if the antiretroviral (ARV) drug zidovudine was given to a woman during pregnancy and labor and delivery and to the newborn. The Pediatric AIDS Clinical Trials Group 076 (PACTG 076) study contributed greatly to preventing MTCT of HIV.